Lonza Group Ltd (Lonza) is a contract manufacturing and development solutions company. It offers services including commercial mammalian and microbial manufacturing, clinical development, and manufacturing. It also offers high potential active pharmaceutical ingredients, cell and gene therapy capabilities, advanced intermediates, oral drug product development services, cell-culture modeling, genome editing, endotoxin products, and research media and testing products. Lonza provides solutions for health and well-being, microbial and hygiene control, and composites and material protection. Lonza serves biotechnology, pharmaceutical, academic, and government research industries; manufacturers of health and consumer products; formulators and service companies. The company operates manufacturing and R&D facilities in Asia, Europe, and the Americas. Lonza is headquartered in Basel, Switzerland.

Headquarters Switzerland

Address Muenchensteinerstrasse 38, Basel, 4002


Telephone 41 61 3168111

No of Employees 17,154

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange LONN (SWF)

Revenue (2020) $5.9B 20% (2020 vs 2019)

EPS XXX

Net Income (2020) XXX 238.8% (2020 vs 2019)

Market Cap* $35.7B

Net Profit Margin (2020) XXX 182.3% (2020 vs 2019)

* As of and is in US$

Access premium data and analytics for Lonza Group Ltd

40+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

30+

Clinical Trials

Determine Lonza Group Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Pipeline Drugs

Identify which of Lonza Group Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

20+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Lonza Group Ltd’s relevant decision makers and contact details.

210+

Install Base

Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.

2

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Lonza Group Ltd (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Lonza Group Ltd’s likely spend across technology areas enabling you to understand the digital strategy.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Services Brands
BioResearch Solutions: Development Technologies Aldo
Stem Cells GS Xceed Gene Expression System Biovert
Primary Cells and Media XS Technologies for Microbial Expression Black Willow Extract
XXX XXX XXX
XXX XXX XXX
XXX XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Corporate Changes/Expansions In September, the company announced the completion of the expansion of Highly Potent API (HPAPI) multipurpose suite in Visp (CH).
2022 Contracts/Agreements In September, the company and Touchlight collaborated on end-to-end mRNA offering.
2022 Plans/Strategy In July, the company announced its plans to build a large-scale commercial drug product fill and finish facility in Stein.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Lonza Group Ltd Royal DSM NV Dottikon ES Holding AG Mabuhay Vinyl Corp ADC Therapeutics SA
Headquarters Switzerland Netherlands Switzerland Philippines Switzerland
City Basel Heerlen Dottikon Makati Epalinges
No. of Employees 17,154 21,760 665 153 312
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Albert M. Baehny Chairman Executive Board 2018 -
Pierre Alain Ruffieux, Ph.D. Chief Executive Officer Senior Management 2020 -
Philippe Deecke Chief Financial Officer Senior Management 2021 -
Caroline Barth Chief Human Resources Officer Senior Management 2020 -
Christoph Mader Vice Chairman Executive Board 2020 -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer